ASSOCIATION OF SERUM CORTISOL AND SERUM PROTEIN IN POSTMENOPAUSAL WOMEN WITH TYPE-2 DIABETES MELLITUS

Abstract

The intricate interplay between hormonal and metabolic factors in post-maturity women with T2DM demands a comprehensive understanding of their interrelationships. This study delves into the connotation between serum cortisol and serum protein levels in postmenopausal women with T2DM, revealing significant insights. Elevated serum cortisol levels are linked to increased serum protein concentrations, indicating a connection to underlying inflammatory processes. This relationship highlights the multifaceted nature of diabetes in this demographic, where hormonal imbalances and chronic inflammation play pivotal roles in disease progression. In this study, hormonal and inflammatory factors need to be considered when assessing and managing T2DM in postmenopausal women. Elevated cortisol not only exacerbates metabolic dysfunction but also promotes a pro-inflammatory state, contributing to amplified levels of acute-phase proteins like C-reactive protein (CRP). These markers of inflammation are linked to cardiovascular diseases and microvascular complications, such as nephropathy, retinopathy, and neuropathy. By advancing our understanding of the association between serum cortisol, serum proteins, and T2DM, we can develop more targeted interventions. Addressing these factors through lifestyle modifications, pharmacological treatments, and stress management techniques can significantly mitigate the adverse effects, ultimately helping to prevent cardiovascular and microvascular complications. This holistic approach is crucial for improving the overall well-being and value of lifespan in postmenopausal females with T2DM.